Filling the need for trusted information on national health issues
The KFF Daily Global Health Policy Report summarized news and information on global health policy, with a focus on U.S. global health policy and developments with potential implications for the U.S. global health response. The Report was published from May 2009 through December 2020.
The Hill: Global Gag Rule is just the tip of the iceberg: Why Repealing the Helms Amendment matters Reps. Jan Schakowsky (D-Ill.), Barbara Lee (D-Calif.), Jackie Speier (D-Calif.), and Ayanna Pressley (D-Mass.) (12/17). Ms. Magazine: The Helms Amendment: 47 Years of Denying U.S. Support for International Reproductive Health and Rights…
Gates Foundation: Looking back at COVID-19 in 2020: A Q&A with Hari Menon “M. Hari Menon, head of the foundation’s India office, wrote on India’s initial COVID-19 response in May 2020. We caught up with him to discuss his thoughts on the pandemic at the end of the year and…
The Conversation: The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 — and then developing multiple vaccines David Pride, associate director of microbiology at the University of California San Diego (12/17). The Guardian: Covid is a chance to build a world where everyone has access…
Brookings Institution’s “Up Front”: How international development donors can collaborate in Southeast Asia George Ingram, senior fellow for global economy and development at the Center for Sustainable Development at Brookings, discusses the advantages and opportunities for, and forms of, international development donor collaboration in Southeast Asia (12/17).
Center for Global Development: DFC’s December Board Meeting: A Fitting Bookend for the Agency’s First Year Clemence Landers, policy fellow, and Jocilyn Estes, program coordinator and policy outreach assistant, both at CGD, discuss the Development Finance Corporation’s (DFC) efforts and portfolio in 2020, writing, “DFC’s inaugural year leaves us with…
Center for Global Development: Questions on the COVID-19 Vaccine? We’ve Got Answers Anthony McDonnell, senior policy analyst at CGD, and Robert Van Exan, president at Immunization Policy and Knowledge Translation, answer nine questions regarding the COVID-19 vaccine pipeline, including questions on vaccine supply and prioritization, clinical trials, and efficacy (12/17).
ONE Campaign: 4 things leaders must do to end the pandemic This blog post outlines four steps governments, companies, and philanthropists involved in the development of a medication or vaccine for COVID-19 must take in order to achieve an equitable path toward ending the pandemic (12/17).
Reuters: EXCLUSIVE — WHO vaccine scheme risks failure, leaving poor countries no COVID shots until 2024 “The global scheme to deliver COVID-19 vaccines to poorer countries faces a ‘very high’ risk of failure, potentially leaving nations home to billions of people with no access to vaccines until as late as…
STAT: One-quarter of the world may not get a Covid-19 vaccine until 2022, experts warn “As wealthy governments race to lock in supplies of Covid-19 vaccines, nearly a quarter of the world’s population — mostly in low- and middle-income countries — will not have access to a shot until 2022,…
